WN-1316
Phase 1- Indications
- Amyotrophic Lateral Sclerosis
Company intelligence / Profile preview
Wakunaga’s flagship product, Kyolic Aged Garlic Extract™, has been the subject of over 900 published scientific papers, including many double-blind, randomized controlled trials. These studies have demonstrated benefits such as lowering blood pressure and cholesterol, slowing progression of atherosclerosis by reducing plaque buildup and calcium deposits in arteries, enhancing circulation, supporting immune function, aiding blood sugar control and liver health. Their probiotic line (“Kyo-Dophilus”) uses proprietary strains shown to improve gut microbiota balance and digestive/immune health. Plant sterol products have also been clinically shown to lower cholesterol and modulate immune response.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wakunaga Pharmaceutical Company.